CYCLIZINE DOSAGE IN SYRINGE DRIVER DOWNLOAD

Experience has indicated that normal adult dosage is appropriate. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. Inability to take medication orally. In children Tablets not licensed for use in children under 6 years. A syringe driver is only an alternative method of administering medication. Symptoms of acute toxicity from cyclizine arise from peripheral anticholinergic effects and effects on the central nervous system. Find out more here.

Uploader:	Shaktijind
Date Added:	15 October 2013
File Size:	12.42 Mb
Operating Systems:	Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X
Downloads:	67237
Price:	Free* [*Free Regsitration Required]

Injection site reactions including vein tracking, erythema, pain, thrombophlebitis and blisters. Anaphylaxis has been recorded following intravenous administration of cyclizine co-administered with propanidid in the same syringe.

Cyclizine Lactate 50 mg/ml Injection - Summary of Product Characteristics (SmPC) - (eMC)

Management In the management of acute overdosage with Valoid, gastric lavage and supportive measures for respiration and circulation should be performed if necessary.

Name of the medicinal product 2. In this article arrow-down Setting up the syringe driver arrow-down Drugs used in the doasge driver arrow-down Drug compatibility arrow-down Problems with syringe drivers. They are used primarily when patients are no longer able to take medicines by mouth.

The relevance of these studies to the human situation is not known. Convulsions should disage controlled in the usual way with parenteral anticonvulsant therapy.

cyyclizine Drug and Indication Dose Other Comments Diamorphine for pain If the patient is not receiving oral morphine, mg per 24 hours, or total oral dose in mg in last 24 hours divided by 3. The exact mechanism by which cyclizine can prevent or suppress both nausea and vomiting from various causes is unknown.

Syringe Drivers

Valoid may mask the warning signs of damage caused by ototoxic drugs such as aminoglycoside antibacterials. Abdominal pain ; agranulocytosis ; angioedema ; anxiety ; apnoea ; appetite decreased ; arrhythmias ; asthenia ; bronchospasm ; constipation ; diarrhoea ; disorientation ; dizziness ; drowsiness ; dry mouth ; dry throat ; euphoric mood ; haemolytic anaemia ; hallucinations ; headache ; hepatic disorders ; hypertension ; hypotension ; increased gastric reflux ; insomnia ; syyringe ; movement disorders dpsage muscle complaints ; nasal dryness ; nausea ; oculogyric crisis ; palpitations disage paraesthesia ; photosensitivity reaction ; seizure ; skin reactions ; speech disorder ; thrombocytopenia ; tinnitus ; tremor ; urinary retention ; vision blurred ; vomiting.

By intravenous injection, or by intramuscular injection. Hepatic dysfunction see section 4.

Qualitative and quantitative composition 3. Active ingredient cyclizine lactate.

By mouth, or by intravenous injection. General side-effects Rare or very rare Angle closure glaucoma ; depression. The N-demethylated derivative, norcyclizine, has been identified as a metabolite of cyclizine. Adverse reactions are ranked under heading of frequency, the most frequent first, using the following convention: Paediatric population Not licensed for use in children. Prescribe one sixth of total hour dose for breakthrough pain.

Also used as anticonvulsant. General disorders and administration site conditions. Syringe Drivers In this article Setting up the syringe driver Drugs used in the syringe driver Drug compatibility Problems with syringe drivers.

Disorientation, restlessness or agitation, nervousness, euphoria, insomnia and auditory and visual inn have been reported, particularly when dosage recommendations have been exceeded.

Cyclizine Lactate 50 mg/ml Injection

Immune system disorders Not known Hypersensitivity reactions, including anaphylaxis have occurred. May cause drowsiness and anticholinergic side-effects.

Some animal studies are interpreted as indicating that cyclizine may be teratogenic at dose levels up to 25 times the clinical dose level. Psychiatric disorders Not known Disorientation, restlessness or agitation, nervousness, euphoria, insomnia and auditory syring visual hallucinations have been reported, particularly when dosage recommendations have been exceeded.

A sensation of heaviness, chills and pruritus have been reported rarely.

Syringe Drivers. Subcutaneous (SC) drug infusion Syringe Driver | Patient

We'd love to send you our articles and latest news by email, giving you the best opportunity to stay up to date with disage written health and lifestyle content. A syringe driver is only an alternative method of administering medication.

Each 1 ml ampoule contains 50 mg cyclizine lactate. Forms available from special-order manufacturers include: Cyclizine was not mutagenic in a full Ames test, including use of S9-microsomes but can nitrosate in vitro to form mutagenic products.